Tanger director granted deferred share units
CITRIN JEFFREY B reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CITRIN JEFFREY B reported acquisition or exercise transactions in this Form 4 filing.
Tanger Inc. director Jeffrey B. Citrin received a grant of 588.92 deferred share units of common stock on May 15, 2026 at a reference price of $35.78 per unit. Each unit equals one common share, payable when his board service ends, bringing his direct holdings to 151,412.42 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 588.92 | $35.78 | $21K |
Footnotes (2)
- F1. Represents deferred share units issued pursuant to the Director Deferred Share Program of Tanger Inc. and Tanger Properties Limited Partnership. Each deferred share unit is equivalent to one common share. The deferred share units become payable in common shares upon termination of his service as a director.
- F2. Since the Reporting Person's last Form 4, 106.97 deferred share units were acquired through a dividend reinvestment program.
Key Figures
Key Terms
dividend reinvestment program financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Tanger Inc. (SKT) report for Jeffrey B. Citrin?
Was Jeffrey Citrin’s Tanger (SKT) transaction an open-market stock purchase?
What does the dividend reinvestment footnote mean in Tanger (SKT) director Citrin’s Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.